D
Profound Medical Corp.
PRN.TO
TSX
D
Sell
2/26/2025Upgraded
Profound Medical Corp. (PRN.TO) was upgraded to D- from E+ on 2/26/2025 due to an increase in the volatility index.
Profound Medical Corp. (PRN.TO) was upgraded to D- from E+ on 2/26/2025 due to an increase in the volatility index.
E
Sell
2/11/2025Downgrade
Profound Medical Corp. (PRN.TO) was downgraded to E+ from D- on 2/11/2025 due to a decline in the total return index and volatility index.
Profound Medical Corp. (PRN.TO) was downgraded to E+ from D- on 2/11/2025 due to a decline in the total return index and volatility index.
D
Sell
1/27/2025Upgraded
Profound Medical Corp. (PRN.TO) was upgraded to D- from E+ on 1/27/2025 due to an increase in the volatility index and valuation index.
Profound Medical Corp. (PRN.TO) was upgraded to D- from E+ on 1/27/2025 due to an increase in the volatility index and valuation index.
E
Sell
9/17/2024Downgrade
Profound Medical Corp. (PRN.TO) was downgraded to E+ from D- on 9/17/2024 due to a decline in the solvency index, growth index and volatility index. Operating cash flow declined 24.56% from -$5.1M to -$6.35M, earnings per share declined from -$0.2551 to -$0.2831, and debt to equity increased from 0.15 to 0.16.
Profound Medical Corp. (PRN.TO) was downgraded to E+ from D- on 9/17/2024 due to a decline in the solvency index, growth index and volatility index. Operating cash flow declined 24.56% from -$5.1M to -$6.35M, earnings per share declined from -$0.2551 to -$0.2831, and debt to equity increased from 0.15 to 0.16.
D
Sell
5/29/2024Upgraded
Profound Medical Corp. (PRN.TO) was upgraded to D- from E+ on 5/29/2024 due to a large increase in the solvency index, growth index and volatility index. Earnings per share increased from -$0.4169 to -$0.2551, debt to equity declined from 0.24 to 0.15, and operating cash flow increased 27.35% from -$7.02M to -$5.1M.
Profound Medical Corp. (PRN.TO) was upgraded to D- from E+ on 5/29/2024 due to a large increase in the solvency index, growth index and volatility index. Earnings per share increased from -$0.4169 to -$0.2551, debt to equity declined from 0.24 to 0.15, and operating cash flow increased 27.35% from -$7.02M to -$5.1M.
E
Sell
5/23/2024Downgrade
Profound Medical Corp. (PRN.TO) was downgraded to E+ from D- on 5/23/2024 due to a decline in the volatility index.
Profound Medical Corp. (PRN.TO) was downgraded to E+ from D- on 5/23/2024 due to a decline in the volatility index.
D
Sell
5/3/2024Upgraded
Profound Medical Corp. (PRN.TO) was upgraded to D- from E+ on 5/3/2024 due to an increase in the volatility index and total return index.
Profound Medical Corp. (PRN.TO) was upgraded to D- from E+ on 5/3/2024 due to an increase in the volatility index and total return index.
E
Sell
4/18/2024Downgrade
Profound Medical Corp. (PRN.TO) was downgraded to E+ from D- on 4/18/2024 due to a decline in the volatility index.
Profound Medical Corp. (PRN.TO) was downgraded to E+ from D- on 4/18/2024 due to a decline in the volatility index.
D
Sell
4/3/2024Upgraded
Profound Medical Corp. (PRN.TO) was upgraded to D- from E+ on 4/3/2024 due to an increase in the volatility index and valuation index.
Profound Medical Corp. (PRN.TO) was upgraded to D- from E+ on 4/3/2024 due to an increase in the volatility index and valuation index.
E
Sell
3/11/2024Downgrade
Profound Medical Corp. (PRN.TO) was downgraded to E+ from D- on 3/11/2024 due to a noticeable decline in the solvency index, growth index and volatility index. Operating cash flow declined 61.76% from -$4.34M to -$7.02M, earnings per share declined from -$0.2615 to -$0.4169, and EBIT declined 33.87% from -$6.56M to -$8.78M.
Profound Medical Corp. (PRN.TO) was downgraded to E+ from D- on 3/11/2024 due to a noticeable decline in the solvency index, growth index and volatility index. Operating cash flow declined 61.76% from -$4.34M to -$7.02M, earnings per share declined from -$0.2615 to -$0.4169, and EBIT declined 33.87% from -$6.56M to -$8.78M.
D
Sell
2/27/2024Upgraded
Profound Medical Corp. (PRN.TO) was upgraded to D- from E+ on 2/27/2024 due to an increase in the volatility index and growth index. Earnings per share increased from -$0.3475 to -$0.2615, operating cash flow increased 15.26% from -$5.12M to -$4.34M, and total revenue increased 7.87% from $1.6M to $1.73M.
Profound Medical Corp. (PRN.TO) was upgraded to D- from E+ on 2/27/2024 due to an increase in the volatility index and growth index. Earnings per share increased from -$0.3475 to -$0.2615, operating cash flow increased 15.26% from -$5.12M to -$4.34M, and total revenue increased 7.87% from $1.6M to $1.73M.
E
Sell
9/13/2023Downgrade
Profound Medical Corp. (PRN.TO) was downgraded to E+ from D- on 9/13/2023 due to a decline in the total return index and volatility index.
Profound Medical Corp. (PRN.TO) was downgraded to E+ from D- on 9/13/2023 due to a decline in the total return index and volatility index.
D
Sell
3/14/2023Downgrade
Profound Medical Corp. (PRN.TO) was downgraded to D- from D on 3/14/2023 due to a major decline in the solvency index and growth index. Earnings per share declined from -$0.2396 to -$0.46, total revenue declined 38.23% from $2.04M to $1.26M, and the quick ratio declined from 14.98 to 12.63.
Profound Medical Corp. (PRN.TO) was downgraded to D- from D on 3/14/2023 due to a major decline in the solvency index and growth index. Earnings per share declined from -$0.2396 to -$0.46, total revenue declined 38.23% from $2.04M to $1.26M, and the quick ratio declined from 14.98 to 12.63.
D
Sell
2/9/2023Upgraded
Profound Medical Corp. (PRN.TO) was upgraded to D from E+ on 2/9/2023 due to an increase in the total return index and volatility index.
Profound Medical Corp. (PRN.TO) was upgraded to D from E+ on 2/9/2023 due to an increase in the total return index and volatility index.
E
Sell
2/8/2023Downgrade
Profound Medical Corp. (PRN.TO) was downgraded to E+ from D on 2/8/2023 due to a decline in the valuation index.
Profound Medical Corp. (PRN.TO) was downgraded to E+ from D on 2/8/2023 due to a decline in the valuation index.
D
Sell
12/16/2022Upgraded
Profound Medical Corp. (PRN.TO) was upgraded to D from D- on 12/16/2022 due to an increase in the volatility index and total return index.
Profound Medical Corp. (PRN.TO) was upgraded to D from D- on 12/16/2022 due to an increase in the volatility index and total return index.
D
Sell
12/1/2022Downgrade
Profound Medical Corp. (PRN.TO) was downgraded to D- from D on 12/1/2022 due to a large decline in the total return index, growth index and solvency index. The quick ratio declined from 17.08 to 14.98, EBIT declined 5.86% from -$7.78M to -$8.23M, and operating cash flow declined 3.36% from -$5.57M to -$5.76M.
Profound Medical Corp. (PRN.TO) was downgraded to D- from D on 12/1/2022 due to a large decline in the total return index, growth index and solvency index. The quick ratio declined from 17.08 to 14.98, EBIT declined 5.86% from -$7.78M to -$8.23M, and operating cash flow declined 3.36% from -$5.57M to -$5.76M.
D
Sell
5/16/2022Upgraded
Profound Medical Corp. (PRN.TO) was upgraded to D from E+ on 05/16/2022.
Profound Medical Corp. (PRN.TO) was upgraded to D from E+ on 05/16/2022.
E
Sell
5/13/2022Downgrade
Profound Medical Corp. (PRN.TO) was downgraded to E+ from D on 5/13/2022 due to a decline in the volatility index, total return index and solvency index. The quick ratio declined from 16.5 to 16.07.
Profound Medical Corp. (PRN.TO) was downgraded to E+ from D on 5/13/2022 due to a decline in the volatility index, total return index and solvency index. The quick ratio declined from 16.5 to 16.07.
D
Sell
5/5/2022Upgraded
Profound Medical Corp. (PRN.TO) was upgraded to D from D- on 05/05/2022.
Profound Medical Corp. (PRN.TO) was upgraded to D from D- on 05/05/2022.
D
Sell
4/20/2022Downgrade
Profound Medical Corp. (PRN.TO) was downgraded to D- from D on 4/20/2022 due to a large decline in the growth index, total return index and solvency index. Earnings per share declined from -$0.2938 to -$0.4891, total revenue declined 60.66% from $2.54M to $998, and EBIT declined 27.88% from -$7.61M to -$9.73M.
Profound Medical Corp. (PRN.TO) was downgraded to D- from D on 4/20/2022 due to a large decline in the growth index, total return index and solvency index. Earnings per share declined from -$0.2938 to -$0.4891, total revenue declined 60.66% from $2.54M to $998, and EBIT declined 27.88% from -$7.61M to -$9.73M.
D
Sell
2/7/2022Downgrade
Profound Medical Corp. (PRN.TO) was downgraded to D from D+ on 2/7/2022 due to a decline in the total return index and volatility index.
Profound Medical Corp. (PRN.TO) was downgraded to D from D+ on 2/7/2022 due to a decline in the total return index and volatility index.
D
Sell
11/11/2021Upgraded
Profound Medical Corp. (PRN.TO) was upgraded to D+ from D- on 11/11/2021 due to an increase in the valuation index.
Profound Medical Corp. (PRN.TO) was upgraded to D+ from D- on 11/11/2021 due to an increase in the valuation index.
D
Sell
11/8/2021Downgrade
Profound Medical Corp. (PRN.TO) was downgraded to D- from D on 11/8/2021 due to a significant decline in the total return index, growth index and volatility index. EBIT declined 19.16% from -$6.38M to -$7.61M, and total revenue declined 3.43% from $2.63M to $2.54M.
Profound Medical Corp. (PRN.TO) was downgraded to D- from D on 11/8/2021 due to a significant decline in the total return index, growth index and volatility index. EBIT declined 19.16% from -$6.38M to -$7.61M, and total revenue declined 3.43% from $2.63M to $2.54M.
D
Sell
5/1/2020Upgraded
Profound Medical Corp. (PRN.TO) was upgraded to D from D- on 5/1/2020 due to a significant increase in the total return index, volatility index and growth index. Total revenue increased 309.89% from $516.7 to $2.12M, earnings per share increased from -$0.4348 to -$0.3291, and EBIT increased 11.18% from -$4.59M to -$4.08M.
Profound Medical Corp. (PRN.TO) was upgraded to D from D- on 5/1/2020 due to a significant increase in the total return index, volatility index and growth index. Total revenue increased 309.89% from $516.7 to $2.12M, earnings per share increased from -$0.4348 to -$0.3291, and EBIT increased 11.18% from -$4.59M to -$4.08M.
D
Sell
10/2/2018Downgrade
Profound Medical Corp. (PRN.TO) was downgraded to D- from D on 10/2/2018 due to a decline in the volatility index and total return index.
Profound Medical Corp. (PRN.TO) was downgraded to D- from D on 10/2/2018 due to a decline in the volatility index and total return index.
D
Sell
9/17/2018Upgraded
Profound Medical Corp. (PRN.TO) was upgraded to D from D- on 9/17/2018 due to an increase in the growth index, solvency index and volatility index. Earnings per share increased from -$0.0505 to -$0.0419.
Profound Medical Corp. (PRN.TO) was upgraded to D from D- on 9/17/2018 due to an increase in the growth index, solvency index and volatility index. Earnings per share increased from -$0.0505 to -$0.0419.
D
Sell
8/6/2018Downgrade
Profound Medical Corp. (PRN.TO) was downgraded to D- from D on 8/6/2018 due to a decline in the valuation index.
Profound Medical Corp. (PRN.TO) was downgraded to D- from D on 8/6/2018 due to a decline in the valuation index.
D
Sell
7/20/2018Upgraded
Profound Medical Corp. (PRN.TO) was upgraded to D from D- on 7/20/2018 due to a noticeable increase in the growth index, volatility index and solvency index. The quick ratio increased from 1.45 to 5.42, debt to equity declined from 0.36 to 0.09, and operating cash flow increased 18.34% from -$3.6M to -$2.94M.
Profound Medical Corp. (PRN.TO) was upgraded to D from D- on 7/20/2018 due to a noticeable increase in the growth index, volatility index and solvency index. The quick ratio increased from 1.45 to 5.42, debt to equity declined from 0.36 to 0.09, and operating cash flow increased 18.34% from -$3.6M to -$2.94M.
D
Sell
10/17/2017None
Profound Medical Corp. (PRN.TO) was downgraded to D- from U on 10/17/2017.
Profound Medical Corp. (PRN.TO) was downgraded to D- from U on 10/17/2017.
